You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Bottom Feeder- A Highly Maneuverable Autonomous Underwater Vehicle
SBC: Tridentis Advanced Marine Vehicles LLC Topic: 822The Bottom Feeder project is designed to prove out the research done in Phase I using a prototype platform. The prototype will be a full size version of the platform designed during Phase I. The Phase I platform was designed to work in two operational configurations, a highly efficient mode and a highly maneuverable mode, with the ability to switch between them while submerged. The platform is equ ...
SBIR Phase II 2019 Department of CommerceNational Oceanic and Atmospheric Administration -
Improving Spatiotemporal Precision in Noninvasive Electrical Neuromodulation
SBC: Brain Electrophysiology Laboratory Company, LLC Topic: 101This application describes the commercialization of the Geodesic Transcranial Electrical Neuromodulation (GTEN) technology to achieve noninvasive neuromodulation with improved spatiotemporal precision. The GTEN system enables both EEG source analysis and configurable electrical neuromodulation with the 256 electrodes of the Geodesic Sensor Net. Now in beta release to selected research customers, t ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT
SBC: Elex Biotech, Inc Topic: NHLBIPROJECT SUMMARY The goal of this project is to complete the preclinical development of Elex Biotechandapos;s novel compounds that target and treat the underlying molecular cause of catecholaminergic polymorphic ventricular tachycardia (CPVT) CPVT. There are no FDA-approved treatments for CPVT, a rare genetic disorder affecting 1/10,000 individuals, with typical onset in children 7-9 years of age a ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies
SBC: ISOPLEXIS CORPORATION Topic: 102While CAR-T therapies have advanced in the clinic, there are still two specific issues using these breakthrough therapies for blood cancers: Durable responses in patients are only at 30-50% and Cytokine Release Syndrome occurs in 60-90% of treated patients. These limitations, for a drug that costs as much as $500,000, may cost an additional $250,000+ for treating adverse events leading to caution ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Mindfulness Mobile App to Reduce Adolescent Substance Use
SBC: OREGON RESEARCH BEHAVIORAL INTERVENTION STRATEGIES, INC. Topic: NIDAAbstract Adolescents in the juvenile justice system demonstrate very high rates of tobacco, alcohol, and other drug use (ATOD), with rates that are estimated to be three times higher than non-justice-involved youth. Substance- abusing youth – especially those who are involved in the juvenile justice system – are at higher risk than nonusers for mental health problems, including depression, con ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
HLS-Affordable, quantitative microchip-electrophoresis for sickle cell disease screening
SBC: HEMEX HEALTH INC Topic: NHLBIPROJECT SUMMARY Sickle Cell Disease (SCD) affects 100,000 Americans and more than 14 million people globally, primarily in economically disadvantaged populations. It is estimated that nearly 50-90% of children born with SCD in these areas die before the age of five, although 70% could be saved through simple, cost-effective treatments if diagnosed early according to World Health Organization. Earl ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
SBC: Volumetrix, LLC Topic: NHLBIVolume overload (congestion) occurs in patients with heart failure (HF) and is the leading cause of hospitalization in the elderly worldwide. Unfortunately, clinical signs and symptoms; laboratory values; and existing diagnostic tools are unreliable in providing accurate assessment of volume status. Using a unique physiologic signal, Non-Invasive Venous waveform Analysis (NIVA), VoluMetrix has dev ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Autoscreen: An innovative e-health solution for early identification of Autism Spectrum Disorder Phase II
SBC: Adaptive Technology Consulting, LLC Topic: 103PROJECT SUMMARY Early accurate identification and treatment of young children with Autism Spectrum Disorder (ASD) represents a pressing public health and clinical care challenge. Given mounting evidence that early, accurate diagnosis of ASD is possible and that very young children who receive intervention can demonstrate substantial gains in functioning, current American Academy of Pediatrics prac ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Multifunctional Semi-Powered Ankle Prosthesis: Phase II
SBC: Synchro Motion LLC Topic: NICHDPROJECT SUMMARY A conventional prosthetic ankle consists of a carbon fiber ankle-foot complex that is nominally configured to a neutral position. These prostheses generally work well for level walking and level-ground standing, but lack the adaptability to explicitly accommodate other terrain or locomotion activities, such as slope walking, slope standing, and stair ambulation. As such, common act ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Expanding the throughput of real-time toxicological screening of cardiac differentiation by expressing a synthetic luciferase/luciferin genetic pathway in iPSCs
SBC: 490 BIOTECH INC Topic: NIEHSExpanding the throughput of real-time toxicological screening of cardiac differentiation byexpressing a synthetic luciferase/luciferin genetic pathway in iPSCs Project Summary This Small Business Innovation Research (SBIR) Phase II project proposes to develop and validate autonomously bioluminescent induced pluripotent stem cells (iPSCs) for use in continuously data producing, reagent-free, and re ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health